erythroblastopenia of childhood are, indeed, an aged population our findings are inconsistent with a steady exponential decay in the activity of enzymes such as hexokinase and suggest that a rapid loss of enzyme from reticulocytes is followed by relatively little further decline in enzyme activity during the remainder of the red cell life span. Pyrimidine-5'-nucleotidase activity, in contrast, seems to be very largely lost in the first few days of red cell life. with CF. From these observations it was suggested that elevated levels of circulating catecholamines might be responsible for an autonomic dysfunction in CF. Other studies indicated that CF patients have increased cholinergic and a,-adrenergic sensitivity in conjunction with reduced P2-adrenergic responses (12). This assumption was drawn from observations in patients who showed altered pupillary reactivity to physical and chemical stimuli (29), relative insensitivity of blood pressure to beta adrenergic bronchodilatation (9, 18) or altered in vitro results from several CF derived cell preparations (fibroblasts, blood cells, tissue explants) (7, 27, 32) . In contrast, Lake et al. (17) reported normal plasma norepinephrine levels and normal activity of DBH in CF patients. It was speculated, therefore, that neither synthesis nor degradation of catecholamines was affected in CF and, that the observed autonomic dysfunction might not be due to circulating biogenic amines.
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with CF. From these observations it was suggested that elevated levels of circulating catecholamines might be responsible for an autonomic dysfunction in CF. Other studies indicated that CF patients have increased cholinergic and a,-adrenergic sensitivity in conjunction with reduced P2-adrenergic responses (12). This assumption was drawn from observations in patients who showed altered pupillary reactivity to physical and chemical stimuli (29) , relative insensitivity of blood pressure to beta adrenergic bronchodilatation (9, 18) or altered in vitro results from several CF derived cell preparations (fibroblasts, blood cells, tissue explants) (7, 27, 32) . In contrast, Lake et al. (17) reported normal plasma norepinephrine levels and normal activity of DBH in CF patients. It was speculated, therefore, that neither synthesis nor degradation of catecholamines was affected in CF and, that the observed autonomic dysfunction might not be due to circulating biogenic amines.
In view of these conflicting results, the present study was designed to elucidate whether circulating plasma catecholamines, their precursors, metabolites and major urinary products are altered in CF patients and heterozygotes, An attempt was made to correlate these findings to the state of the disease, different blood variables, blood pressure, and heart rate as well as to the sweat electrolyte abnormality.
MATERIALS AND METHODS

Patients and controls.
Blood and 24-h urine samples were collected from 43 children and adolescents with CF (26 boys and 17 girls, range 8-23 yr) attending a summer camp for intensive physiotherapy treatment in a mountain rehabilitation center. All children were treated with the same drug, pancrease (Prolipase), for supplementation of pancreatic insufiiciency, all had the same daily meals and equal daily inhalation therapy with a P2-sympathomimetic drug (hexoprenaline-sulfate, Ipradol). Thirty-five patients received antibiotics orally; no intravenous or further drug therapy was used. All children attended the same physical training and physiotherapy regimen. All children and parents gave informed consent to participate in the study.
In 25 parents a single blood specimen could be obtained at the time of admission of the children to the rehabilitation center. Eight healthy adults without a family history of CF served as controls and were investigated at the same time. Values from normal healthy children, collected over several years and measured in the laboratory, performing daily routine catecholamine determinations were randomly selected as age matched and used as controls.
Clinical investigation and laboratory methods. Clinical state, weight, height, blood pressure, and heart rate were evaluated at the admission to the clinic. Chest radiographic scores were determined by the Chrispin Norman scoring system (5). Each child had a sweat test on the day of blood sampling performed by the Webster Sweat Stimulation/Collection system with osmolality determinations (30) . Blood gas analysis (ear oxymetry) and determinations of total protein, electrolytes, creatinine, SCOT, SGPT, plasma osmolality, copper, and ceruloplasmin were done by routine laboratory methods.
Collection of samples. In the CF patients, after an 8-h or more overnight rest, blood samples were collected by acute needle stick from the cubital vein with heparin and placed immediately on ice. By the same procedure blood was drawn from the parents after a short rest in supine position. The eight controls were treated accordingly. The plasma was quickly separated by centrifugation, decanted, and frozen, All samples were stored at -20" C until used (determinations done within 10 days; experiments performed on days 1 and 10 showed no activity change during that storing period).
Determination of catecholamines and their metabolites in urine. The extraction of the catecholamine acids was done using Clin Elute extraction columns (Analytichem International, Inc, Harbor City, CA). VMA, HVA, and 5-HIAA were determined by high pressure liquid chromatography with electrochemical detection as described by Kissinger et al. (1 5) and Mattiuz et al. (20) . The system contained a Kontron Analytic Programmer 200, a Kontron Analytic pump 410, an injection value Rheodyne 7125, a 5 p Ultrasphere Biophase ODs column, 4.6 x 250 mm (Beckman Instruments), and a LC 3 amperometric detector with a LC 17 oxidative flow cell containing a glassy carbon working electrode (Bioanalytical Systems, Inc, West Lafayette, IN); the mobil phase was 0.15 M monochloroacetate buffer, pH 3.0 containing 2 mM Na2EDTA and 300 mg/liter sodium octyl sulfate with 8% acetonitrile. The flow rate was 1.5 ml/min at a temperature of 28" C and the amount injected was 10 p1. Peak heights were determined by a Spectra Physics Mod 4100 electronic integrator.
Free E, NE, DA and MN, NM, 3-MT were isolated from the urine by the ion exchange procedure of Carlson and Waldeck (4). The catecholamines and their metabolites were assayed fluorimetrically by the method of Kaser (14). All values were expressed in pmol or nmo1/24 h or in nmol/pmol of urinary creatinine, measured by a modified Jaffe reaction (22).
Determinations of plasma catecholamines and of DBH. Simultaneous radioenzymatic determinations of E, NE, and DA were done according to the method of Passon and Peuler (24), Peuler and Johnson (25), and Da Prada and Ziircher (6) using COMT from pig liver, prepared by the method of Axelrod and Tomchick (1) . The photometric assay of Nagatsu and Udenfriend (2 1) was used for the determinations of plasma DBH.
Statistics. Since many of the determined variables are age dependent we devided controls and patients randomly into three groups: age group 5-9 yr ( n for CF = 5), age group 10-14 yr ( n = 19), and age group 15-19 yr ( n = 19). In the latter group, two patients older than 19 yr (21 and 23 yr) were included. In our hands, this age grouping proved to be accurate to evaluate patients with neuroblastoma and/or pheochromocytoma due to elevated plasma and urinary catecholamines (14). Statistical analysis was performed by the nonparametric Wilcoxon-MannWhitney test and the Spearman rank correlation. Table 1 shows some of the anthropometric and serum data of the CF patients. The values for electrolytes, creatinine clearance, blood pressure, and heart rate were not statistically significant different from normal values for age. However, 10 children had slightly elevated transaminases, one in the youngest age group, six in the middle, and three in the oldest age group. The mean copper concentration in the plasma of all patients was 22.5 -t-3.6 pmol/liter (mean rt SD) with a corresponding caeruloplasmin concentration of 0.23 + 0.02 g/liter. Therefore, as compared to normal values, nine CF had patients slightly elevated plasma copper and caeruloplasmin concentrations.
RESULTS
Sweat osmolality was elevated in all 43 children, showing a mean value of 264 + 20 mmol/kg (mean + SD) ranging from 190-302 mmol/kg, values which are diagnostic for CF (30) .
The 24-h urine production of CF patients was slightly, but not significantly higher than that of control children (not shown). No differences in the urine creatinine concentrations between CF and normals were present.
As shown in Figure 1 the VMA and HVA excretion over 24 h and the concentration per pmol urinary creatinine were age dependent and showed no difference between patients and controls. Furthermore, the free urinary E, NE, and DA (results not shown) were normal in CF as were the total 0-methylated products, MN, NM, and 3-MT. Figure 2 shows the results of the urinary excretion of 5-HIAA. An age-dependent increase which resulted in a significantly higher excretion of 5-HIAA for the oldest age group was found. Table 2 gives the median and range values for free plasma, E, NE, DA, and DBH. Compared to controls, significantly elevated values of free plasma dopamine were present in the CF patients Interestingly, no significant linear correlation of urinary DA to plasma DA levels could be demonstrated (r = 0.347). Also the final breakdown product of DA in urine, the HVA, was not correlated to the plasma DA levels. Plasma DA levels were neither related to the nutrient intake nor to the type and dose of drugs used. Obviously, the age-dependent plasma DA decrease observed in controls could not be found in CF. No abnormalities in plasma levels of E, NE, and DA (E: 0.076-0.604; NE: 0.91-3.84; DA: 0.08-1.48; indicated are ranges in nmollliter) could be demonstrated in the parents of patients when compared to the adult controls. DBH activity varied greatly in controls, parents, and patients: no differences or correlations could be established. Since this enzyme contains copper we attempted to relate its activity to plasma copper concentrations and to copper-binding protein.
No dependence was obvious and there was no link between the parent's DBH activity and that found in their children.
DISCUSSION
This study shows normal excretion of the phenolic acids (VMA, HVA) in CF patients. Furthermore, the free urinary amines, E, NE, and DA as well as their 0-methylated products MN, NM, and 3-MT were within the normal range for age. In addition, an age-dependent increase of the 5-HIAA excretion in urine was noticed. On the other hand, in plasma, besides normal E and normal DBH, significantly elevated DA concentrations and slightly higher NE values were detected in the CF patients. As shown in Figure 3 , E, NE, and DA are synthesized via DOPA form the amino acid tyrosine. The metabolism of these catecholamines is regulated mainly by a few elementary types of enzymatically catalyzed reactions, i.e. hydroxylation, methyation, acetylation, oxodative deamination, and conjugation to sulfate or glucuronide (10). Each metabolic product tends to traverse one main synthetic or catabolic pathway leading to numerous substances, which in turn can be stored, further metabolized, or excreted. It is generally accepted that the main breakdown product of dopamine is HVA, and of epinephrine/ norepinephrine, VMA. The determination of these phenolic acids in urine therefore provides some insight into the function of the sympathoadrenal system.
The finding of elevated free urinary catecholamines in CF has been cited by several authors (8, 9, 29). However, these results have never been reproduced by modem laboratory techniques. For several years therefore the possibility of a disturbed autonomic regulation in CF has been suggested (19). Our results indicating normal urinary VMA and HVA argue against a main alteration in the peripheral sympathetic autonomic regulation. This conclusion can be underlined by the fact that normal excretion of free E, NE, and DA and of their 0-methylated products was observed. Further evidence for this assumption is provided by the normal plasma DBH activity confirming the findings of Lake et al. (17).
However, the striking feature of our study is the significantly elevated plasma dopamine concentration contrasted with the normal urinary dopamine and normal HVA. The most important metabolic pathway for dopamine is its hydroxylation to NE, a reaction catalyzed by DBH. On the other hand, dopamine can be deaminated oxodatively to DOPAC by M A 0 or 0-methylated to 3-MT by COMT; from these two resulting compounds homovanillic acid is derived. A further important possibility of inactivation is either a reuptake of DA into nerve endings or its S C H~N I ET AL. * p < 0.00 1 for normals and CF.
conjugation to sulfate or glucuronide (16). It appears from several recent reports that the formation of the sulfoconjugate is the preferential pathway for the inactivation and excretion of DA, as well as for other catecholamines. Since the free urinary catecholamines E, NE, and DA were normally excreted by the CF patients we also determined the sulfoconjugated compound in eight children. No alterations were found and it seems that no sulfoconjugation defect for these catecholamines in CF is present. Our results of the plasma control NE levels are in agreement with those values published by Lake et al. (17) . However, our NE concentrations of age comparable CF patients are about 2 fold higher. This discrepancy might be based on different CF patients investigated; our patients in the oldest age group had a severer degree of disease than those reported by Lake et al. (17) , who were in good to excellent condition. Despite the absence of a direct correlation of disease severity with our plasma catecholamine levels, we believe that chronic hypoxia influenced basal NE levels. Whether an appropriate catecholamine response to an acute hypoxic stimulus occurs in CF patients or whether chronic hypoxia turns down the physiological regulation remain to be determined. It is not surprising that in an heterogenous group of CF patients with different lung involvement and fluctuating capillary p02 and pC02 tension (due to the presence of different degree of lung infection or simply due to different temporarely effective or ineffective physiotherapy) no direct correlations of plasma catecholamine levels and disease severity could be established. It has been shown during pubescence that the chronological age of CF patients might not reflect the physiologic age; therefore our age grouping might be inadequate. In fact, this could have influenced our NE values for the middle age group which actually revealed somewhat elevated levels. However, this would not explain the overall elevation for the dopamine in all age groups.
Whether blood sampling techniques alter endogenous catecholamine levels is not clear, and reports in children are not available. According to Robertson et al. (26) direct venepuncture versus heparin-lock sampling did not affect mean plasma E, NE, and DA levels. We also believe that in children an acute venepuncture by a small needle is a much milder and less traumatic procedure than the insertion of an indwelling catheter which must be held in position and heparin locked. In our hands heparin-locked catheters generated problems in smaller children and in patients with higher hematocrits because of catheter pluging. The manipulation required to sample blood after such an event generate more stress in children than a quickly done acute venepuncture. Furthermore ethical reasons of performing such manipulations must be taken into consideration. It seems very unlikely that our technique increased the DA levels in the PHENYLALAN INE CF we suggest that the degree of the pulmonary involvement might contribute to the elevated 5-HIAA in urine.
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